Načítá se...
Cardiovascular disease management during the coronavirus disease 2019 pandemic
Based on clinical presentation, pathophysiology, high infectivity, high cardiovascular involvement, and therapeutic agents with cardiovascular toxicity of coronavirus disease 2019 (COVID-19), regular cardiovascular treatment is being changing greatly. Despite angiotensin-converting enzyme 2 serving...
Uloženo v:
| Vydáno v: | Int J Med Sci |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Ivyspring International Publisher
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7330658/ https://ncbi.nlm.nih.gov/pubmed/32624690 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.46484 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|